Age and gender predict the outcome of treatment for Graves' hyperthyroidism

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 1038-1042

  Allahabadia, Amit ^a,b   Daykin, Jacquie ^a   Holder, Roger L ^a   Sheppard, Michael C ^a   Gough, Stephen C L ^a   Franklyn, Jayne A ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; LIOTHYRONINE; RADIOACTIVE IODINE; THYROGLOBULIN ANTIBODY; THYROID PEROXIDASE; THYROTROPIN; THYROXINE;

ADULT; AGE; AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GENDER; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; REMISSION; SMOKING; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGING; ANTITHYROID AGENTS; CHILD; COHORT STUDIES; DATABASES, FACTUAL; FEMALE; GOITER; GRAVES DISEASE; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEX CHARACTERISTICS; SMOKING; TREATMENT OUTCOME;

EID: 0034453809     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.3.1038     Document Type: Article

References (32)

1. The spectrum of thyroid disease in a community: The Whickam survey
2. The management of hyperthyroidism
3. Differences and similarities in the diagnosis and treatment of Graves' disease in Europe, Japan and the United States
4. The management of hyperthyroidism due to Graves' disease in Europe in 1986. Results of an international survey
5. Clinical features of patients with Graves' disease undergoing remission after antithyroid drug treatment
6. Prospective multicentre study on the prediction of relapse after antithyroid drug treatment in patients with Graves' disease
7. Prediction of outcome in Graves' disease after carbimazole treatment
8. Factors influencing the outcome of thyrostatic drug therapy in Graves' disease
9. Prediction of relapse in hyperthyroid Graves' disease
10. Goitre size and outcome of medical treatment of Graves' disease
11. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism
12. Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules
13. Upper airways obstruction in patients presenting with thyroid enlargement
14. Linkage disequilibrium between the HLA class II region of the MHC and Graves' disease: Replication using a population case control study and family based study
15. Modification of the classification of the eye changes in Graves' disease; recommendations of the ad hoc committee of the American Thyroid Association
16. Dissociation of responsiveness to thyrotropin-releasing hormone and thyroid suppressibility following antithyroid drug therapy of hyperthyroidism
17. Serum triiodothyronine to thyroxine ratio: A newly recognised predictor of outcome of hyperthyroidism due to Graves' disease
18. Thyroid function and immunological activity during and after medical treatment of Graves' disease
19. Is there a methimazole dose effect on remission rate in Graves' disease? Results from a long-term prospective study
20. Sex Hormones, glucocorticoids, and autoimmunity: Facts and hypotheses
21. Hormonal regulation of immune responses
22. The thyroid gland
23. Graves' disease. Influence of age on clinical findings
24. Age-related changes of thyroid function and immunologic abnormalities in patients with hyperthyroidism due to Graves' disease
25. Hyperthyroidism in the elderly
26. Age and gender influence the severity of thyroid-associated ophthaimopathy: A study of 101 patients attending a combined thyroid-eye clinic
27. Age-related therapeutic response to antithyroid drug in patients with hyperthyroid Graves' disease
28. Hypothyroidism as a late sequela in patients with Graves' disease treated with antithyroid agents
29. Success rate of radioiodine therapy in Graves' disease: The influence of thyrostatic medication
30. Do HLA Dr-typing and measurement of TSH-receptor antibodies help in the prediction of the clinical course of Graves' thyrotoxicosis after antithyroid treatment
31. Consensus statement for good practice and audit measures in the management of hypothyroidism and hyperthyroidism
32. Cancer incidence and mortality after radioiodine treatment for hyperthyroidism: A population-based cohort study